journal article·2022-10

Scavenging of reactive oxygen species can adjust the differentiation of tendon stem cells and progenitor cells and prevent ectopic calcification in tendinopathy

Haotian Shen, Linxiang Cheng, Qiangqiang Zheng, Wenduo Liu, Yue Wang

Acta Biomaterialia· Volume 152
Publisher page

Abstract

Tendinopathy is a common disorder that leads to pain and impaired quality of life. Recent studies revealed that osteogenic differentiation of tendon stem/progenitor cells (TSPCs) played an important role in the pathogenesis of tendon calcification and tendinopathy. In this study, we found that the growth hormone-releasing hormone agonist (GA) can prevent matrix degradation and osteogenic differentiation in TSPCs. As oxidative stress is a key factor in the osteogenic differentiation of TSPCs, we used bovine serum albumin/heparin nanoparticles (BHNPs), which have biocompatibility and drug loading capacity, to scavenge reactive oxygen species (ROS) and achieve sustained release of GA at the site of inflammation. The newly developed BHNPs@GA had a synergetic effect on reducing ROS production in TSPCs. In addition, BHNPs@GA effectively inhibited tendon calcification and promoted collagen formation in a rat model of tendinopathy. Focusing on the ROS underlying the differentiation and dedifferentiation of TSPCs, this work demonstrated that sustained release of GA targeting ROS and ectopic ossification is a practical therapeutic strategy for treating tendinopathy. STATEMENT OF SIGNIFICANCE: Osteogenic differentiation of tendon stem/progenitor cells (TSPCs) plays an important role in the pathogenesis of ectopic calcification in tendinopathy. In this study, we found that growth hormone-releasing hormone agonist (GA) can reduce reactive oxygen species (ROS) production and adjust TSPCs differentiation. Bovine serum albumin/heparin nanoparticles (BHNPs) were developed to encapsulate GA and achieve sustained release of GA at the site of inflammation. The developed compound, BHNPs@GA, with a synergistic effect of inhibiting ROS and thus, can effectively adjust TSPCs differentiation, inhibit tendon calcification, and promote collagen formation in tendinopathy. This study highlighted the role of ROS underlying the differentiation and dedifferentiation of TSPCs in tendinopathy, and findings may help to identify new therapeutic targets and develop novel strategy for treating tendinopathy.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Tendon Structure and Treatment · Shoulder Injury and Treatment · Sports injuries and prevention

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (72)

Show source-provided references
1. Inflammatory mechanisms in tendinopathy - towards translation10.1038/nrrheum.2016.213 ↗
2. Review: Emerging concepts in the pathogenesis of tendinopathy10.1016/j.surge.2017.05.005 ↗
3. Incidence of rotator cuff tears in the setting of calcific tendinopathy on MRI: a case controlled comparison10.1007/s00256-018-3018-1 ↗
4. Insertional calcific tendinopathy of the achilles tendon and dysmetabolic diseases: an epidemiological survey10.1097/JSM.0000000000000881 ↗
5. What understanding tendon cell differentiation can teach us about pathological tendon ossification
6. Physiopathology of intratendinous calcific deposition10.1186/1741-7015-10-95 ↗
7. Rotator cuff calcific tendinopathy: from diagnosis to treatment
8. Post-surgical Achilles calcific tendinopathy treated with ultrasound-guided percutaneous irrigation10.1007/s00256-020-03453-5 ↗
9. Ultrasound-guided percutaneous irrigation of rotator cuff calcific tendinosis. What radiologist should know10.5114/pjr.2022.113491 ↗
10. Tendon injury and repair - A perspective on the basic mechanisms of tendon disease and future clinical therapy10.1016/j.actbio.2017.08.032 ↗
11. Mechanical loading modulates heterotopic ossification in calcific tendinopathy through the mTORC1 signaling pathway10.3892/mmr.2017.7380 ↗
12. Pharmacological regulation of in situ tissue stem cells differentiation for soft tissue calcification treatment10.1002/stem.2306 ↗
13. Targeted pathological collagen delivery of sustained-release rapamycin to prevent heterotopic ossification10.1126/sciadv.aay9526 ↗
14. Achilles tendon biomechanics in response to acute intense exercise10.1519/JSC.0000000000000361 ↗
15. The pathogenesis of Achilles tendinopathy: a systematic review10.1016/j.fas.2014.02.010 ↗
16. Endochondral ossification in Achilles and patella tendinopathy10.1093/rheumatology/41.4.474 ↗
17. Tendon-derived stem cells (TDSCs) promote tendon repair in a rat patellar tendon window defect model10.1002/jor.21559 ↗
18. Bone marrow mesenchymal stem cell-derived exosomes promote tendon regeneration by facilitating the proliferation and migration of endogenous tendon stem/progenitor cells10.1016/j.actbio.2020.01.051 ↗
19. Mkx-deficient mice exhibit hedgehog signaling-dependent ectopic ossification in the achilles tendons10.1002/jbmr.3630 ↗
20. Tendon-derived cathepsin K-expressing progenitor cells activate Hedgehog signaling to drive heterotopic ossification10.1172/JCI132518 ↗
21. Tendinopathy and tendon material response to load: what we can learn from small animal studies10.1016/j.actbio.2021.07.046 ↗
22. Reactive oxygen species (ROS)-based nanomedicine10.1021/acs.chemrev.8b00626 ↗
23. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents10.1038/s41580-020-0230-3 ↗
24. Physical, chemical, and biological structures based on ROS-sensitive moieties that are able to respond to oxidative microenvironments10.1002/adma.201505376 ↗
25. Reactive oxygen species and tendinopathy: do they matter?10.1136/bjsm.2004.012351 ↗
27. Development of PEGylated serum albumin with multiple reduced thiols as a long-circulating scavenger of reactive oxygen species for the treatment of fulminant hepatic failure in mice10.1016/j.freeradbiomed.2014.01.036 ↗
28. Regulation of vascular calcification by growth hormone-releasing hormone and its agonists10.1161/CIRCRESAHA.117.312418 ↗
29. Autophagy prevents oxidative stress-induced loss of self-renewal capacity and stemness in human tendon stem cells by reducing ROS accumulation10.1159/000447916 ↗
30. Chemokines and disease10.1038/84209 ↗
31. In vitro temporal HIF-mediated deposition of osteochondrogenic matrix governed by hypoxia and osteogenic factors synergy10.1002/jcp.30138 ↗
32. Ceria nanoparticles meet hepatic ischemia-reperfusion injury: the perfect imperfection10.1002/adma.201902956 ↗
33. Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases10.1038/s41467-020-16544-7 ↗
34. A silica-based antioxidant nanoparticle for oral delivery of Camptothecin which reduces intestinal side effects while improving drug efficacy for colon cancer treatment10.1016/j.actbio.2022.02.036 ↗
35. Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities10.1016/j.peptides.2013.12.010 ↗
36. Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction10.1073/pnas.0914138107 ↗
37. Profound actions of an agonist of growth hormone-releasing hormone on angiogenic therapy by mesenchymal stem cells10.1161/ATVBAHA.116.307126 ↗
38. S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cells10.1073/pnas.1220185110 ↗
39. Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice10.1073/pnas.1518540112 ↗
40. Protective effect of Growth Hormone-Releasing Hormone agonist in bacterial toxin-induced pulmonary barrier dysfunction10.3389/fphys.2014.00259 ↗
41. A thermosensitive, reactive oxygen species-responsive, MR409-encapsulated hydrogel ameliorates disc degeneration in rats by inhibiting the secretory autophagy pathway10.7150/thno.47723 ↗
42. Stability of peptides and therapeutic success in cancer10.1517/17425255.2011.574126 ↗
43. Stromal cell-derived factor-1alpha-encapsulated albumin/heparin nanoparticles for induced stem cell migration and intervertebral disc regeneration in vivo10.1016/j.actbio.2018.03.032 ↗
44. Stepwise differentiation of human embryonic stem cells promotes tendon regeneration by secreting fetal tendon matrix and differentiation factors10.1002/stem.61 ↗
45. Pharmacological Inhibition of Rac1 Activity Prevents Pathological Calcification and Enhances Tendon Regeneration10.1021/acsbiomaterials.9b00335 ↗
46. Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway10.1038/s41467-021-24643-2 ↗
47. Electrospun scaffolds for multiple tissues regeneration in vivo through topography dependent induction of lineage specific differentiation10.1016/j.biomaterials.2014.12.027 ↗
48. Establishment of a resource recycling strategy by optimizing isobutanol production in engineered cyanobacteria using high salinity stress10.1186/s13068-021-02023-8 ↗
49. Nanoceria provides antioxidant and osteogenic properties to mesoporous silica nanoparticles for osteoporosis treatment10.1016/j.actbio.2020.12.029 ↗
50. Chronic inflammation is a feature of Achilles tendinopathy and rupture10.1136/bjsports-2017-098161 ↗
51. Achilles tendinopathy10.1097/JSA.0b013e3181a3d625 ↗
52. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche10.1038/nm1630 ↗
53. An asymmetric chitosan scaffold for tendon tissue engineering: in vitro and in vivo evaluation with rat tendon stem/progenitor cells10.1016/j.actbio.2018.04.027 ↗
54. Tendon stem/progenitor cells and their interactions with extracellular matrix and mechanical loading10.1155/2019/3674647 ↗
55. Tendon stem/progenitor cell subpopulations and their implications in tendon biology
56. Immunogenic cell death and DAMPs in cancer therapy10.1038/nrc3380 ↗
57. High cholesterol induces apoptosis and autophagy through the ROS-activated AKT/FOXO1 pathway in tendon-derived stem cells10.1186/s13287-020-01643-5 ↗
58. Mitochondrial dysfunction and potential mitochondrial protectant treatments in tendinopathy10.1111/nyas.14599 ↗
59. Small molecule therapeutics for inflammation-associated chronic musculoskeletal degenerative diseases: past, present and future10.1016/j.yexcr.2017.07.027 ↗
60. Oligonucleotide-functionalized hydrogels for sustained release of small molecule (aptamer) therapeutics10.1016/j.actbio.2019.11.037 ↗
61. Endothelial cell-targeting, ROS-ultrasensitive drug/siRNA co-delivery nanocomplexes mitigate early-stage neutrophil recruitment for the anti-inflammatory treatment of myocardial ischemia reperfusion injury10.1016/j.actbio.2022.02.018 ↗
62. An all-in-one CO gas therapy-based hydrogel dressing with sustained insulin release, anti-oxidative stress, antibacterial, and anti-inflammatory capabilities for infected diabetic wounds
63. Bovine serum albumin as a versatile platform for cancer imaging and therapy10.2174/0929867324666170314143335 ↗
64. The tendon microenvironment: Engineered in vitro models to study cellular crosstalk10.1016/j.addr.2022.114299 ↗
65. ROS-responsive 18beta-glycyrrhetic acid-conjugated polymeric nanoparticles mediate neuroprotection in ischemic stroke through HMGB1 inhibition and microglia polarization regulation
66. Inflammation responsive logic gate nanoparticles for the delivery of proteins10.1021/bc200141h ↗
67. ROS-responsive microspheres for on demand antioxidant therapy in a model of diabetic peripheral arterial disease10.1016/j.biomaterials.2014.11.016 ↗
68. Characteristics of sonography in a rat achilles tendinopathy model: possible non-invasive predictors of biomechanics10.1038/s41598-017-05466-y ↗
69. Non-invasive ultrasound quantification of scar tissue volume identifies early functional changes during tendon healing10.1002/jor.24397 ↗
70. The role of animal models in tendon research10.1302/2046-3758.36.2000281 ↗
71. Tendon injury: from biology to tendon repair10.1038/nrrheum.2015.26 ↗
72. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy10.1136/bjsm.2008.051193 ↗